89 papers found
Refreshing results…
Additional file 2: Tables S1a-d. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Additional file 3: Figure S2. of Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Additional file 4: Figure S3. of Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Additional file 3: Figure S1a-c. of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Additional file 1: of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Biomarkers and Methodologies for Monitoring Epigenetic Drug Effects in Cancer
Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
Additional file 4: of TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Additional file 5: Figure S4. of Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
List of Contributors
Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome
Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients
Allele-Specific DNA Methylation Detection by Pyrosequencing®
DNA Methylation Profiling of Sorted Cells from Myelofibrosis Patients reveals Aberrant Epigenetic Regulation of Immune Pathways and identifies Early MPN Driver Genes
Supplementary Material
Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma
Genotyping common FSHR polymorphisms based on competitive amplification of differentially melting amplicons (CADMA).
ELMO3 : A direct driver of cancer metastasis?
Hypomethylation and increased expression of the putative oncogene ELMO3 are associated with lung cancer development and metastases formation
Predicting response to epigenetic therapy
Missing publications? Read more about our data sources.